1ZHANG Y, ZHOU X, KREPINSKY J C, et al. Association study between fibronectin and coronary heart disease[J]. Clin Chem Lab Med, 2006,44 : 37- 42.
2SULLIVAN D R, MARWICK T H, FREEDMAN S B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk faetors[J]. Am Heart J, 1990,119:1262-1267.
3CHO J, MOSHER D F. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi[J]. Blood, 2006, 107:3555-3563.
4CHO J, MOSHER D F. Role of fibromectin assembly in platelet thrombus formation[J]. J Thromb Haemost, 2006,4 : 1461 - 1469.
5KIM H J, KIM M Y, JIN H, et al. Peroxisome proliferator-activated receptor {delta} regulates extracellular matrix and apoptosis of vascular smooth muscle ceils through the activation of transforming growth factor-{ beta} 1/Smad3[J]. Cire Res, 2009,105: 16- 24.
6MOI.OSSI S, CLAUSELL N, RABINOVITCH M.Reciprocal induction of tumor necrosis factor-alpha and interleukin-1 beta activity mediates fibronectin synthesis in coronary artery smooth muscle cells[J]. J Cell Physiol, 1995,163: 19 - 29.
7CHEN H C, GUH J Y, SHIN S J, et al. Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose[J]. Atherosclerosis, 2002,160 : 141- 146.
8XIN X, KHAN Z A, CHEN S, et al. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis[J]. Lab Invest, 2004,84 : 1451 - 1459.
9SHOJAIE M, POURAHMAD M, ESHRAGHIAN A, et al. Fibrinogen as a risk factor for premature myocardial infarction in iranian patients: A case control study[J]. Vas Health Risk Manag, 2009 : 5 : 673- 676.
10OMRAN M T, ASADOLLAHI S. The measurement of serum fibrinogen levels in patients with acute coronary syndrome[J]. Saudi Med J, 2007,28 : 1350- 1352.
